Detecting early stage lung cancer

Israeli biotech BioView Ltd has announced that it has signed a cooperation agreement with OncoMDx of California, to develop a non-invasive diagnostic test for the early detection of non-small cell lung cancer (NSCLC). NSCLC accounts for 85% of all lung cancer cases.
http://www.globes.co.il/serveen/globes/docview.asp?did=1000730852&fid=1725

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *